Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02076217 · ClinicalTrials.gov registry record
Quick Start of Highly Effective Contraception
A clinical trial of Contraception and IUD, sponsored by University of Utah.
- Active
- Registry status
- 1,030
- Enrollment target
- 1
- Study location
NCT02076217: Active study of Contraception and IUD, sponsored by University of Utah.
NCT02076217 is a study of Contraception and IUD that is active but no longer recruiting, run by University of Utah. The registered enrollment target is 1,030 participants, above the 440-participant average among 72 other Contraception trials with a reported enrollment target (134% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02076217, a study of Contraception and IUD, is active but no longer recruiting, sponsored by University of Utah.
- ACTIVE NOT RECRUITING
- Registry status
- 1,030 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will quantify rates of contraceptive failure when unprotected intercourse occurs 6-14 days prior to initiation of highly effective reversible contraceptives (such as IUD's and Implants).
Primary Outcome
This study is designed to provide clinicians and their patients with information regarding rates of contraceptive failure (i.e. undesired pregnancy) when contraception is initiated or placed for a woman who has a negative pregnancy test, but reports having had unprotected intercourse 6-14 days prior to requesting contraception.
Conditions Studied
Interventions
- DRUG Copper T-380 IUD
- DRUG LNG IUD
- DEVICE Contraceptive implant Nexplanon
- DRUG Depo-Provera
Study Locations (1)
Utah
- Planned Parenthood Association of Utah - West Valley City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,030 participants |
| Start Date | 2014-02 |
| Est. Completion | 2026-01 |
What the registry record for NCT02076217 still lists
NCT02076217 is an observational study that tracks outcomes without assigning an intervention. Its 1,030 participants enrollment target places it among the larger protocols in the corpus, above the 440-participant average among 72 other Contraception trials with a reported enrollment target (134% higher).
The record links to 5 conditions, with Contraception appearing as the primary indexed condition, and to 4 interventions - of which Copper T-380 IUD is the first listed.
NCT02076217 reports a single indexed study location in Utah.
Frequently Asked Questions
What is clinical trial NCT02076217 about?
NCT02076217 is a clinical study titled "Quick Start of Highly Effective Contraception". This project will quantify rates of contraceptive failure when unprotected intercourse occurs 6-14 days prior to initiation of highly effective reversible contraceptives (such as IUD's and Implants).
What is the current status of trial NCT02076217?
This trial is currently active not recruiting. The enrollment target is 1,030 participants. The study started on 2014-02. Estimated completion is 2026-01.
What conditions does trial NCT02076217 study?
This clinical trial studies the following conditions: Contraception, IUD, Emergency Contraception, Birth Control, Contraceptive Implant.
What interventions are being tested in trial NCT02076217?
The interventions under investigation include: Copper T-380 IUD (DRUG), LNG IUD (DRUG), Contraceptive implant Nexplanon (DEVICE), Depo-Provera (DRUG).
Who is sponsoring clinical trial NCT02076217?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02076217 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Contraception
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02076217's enrollment target sits among peer trials
1,030 11th of 72 higher than 62 of 72 other Contraception trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Oral Contraceptive Pill (OCP) Pharmacogenomics
RECRUITING · Phase 4
-
Intravenous Ketorolac Administration to Attenuate Post-procedural Pain Associated With Intrauterine Device Placement
RECRUITING · Phase 4
-
Patient-clinical Linkages to Improve Trust and Engagement in Postpartum Healthcare
RECRUITING · NA
-
Empathy Through Pain Control: Lidocaine Paracervical Block for IUD Placements
RECRUITING · NA
-
Hormonal Contraception Access Through Pharmacist Prescribing Implementation
RECRUITING · NA
-
Prospective Multi-Center Trial for FemBloc Permanent Birth Control
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06080698 · 1,030 participants · NA
Gram-Negative Bloodstream Infection Oral Antibiotic Therapy Trial
- NCT07084363 · 1,032 participants · NA
Quantitative Versus qUAlitative NeuromoniToring of neUroMuscular Block for Non-cardiothoracic Surgery
- NCT05037682 · 1,035 participants · NA
Pain and Opioid Management in Older Adults
- NCT07282600 · 1,035 participants · Phase 3
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia